Glioblastoma – or glioblastoma multiforme – is an aggressive type of brain tumor for which there is currently no cure and which usually results in death within a few months of diagnosis. Glioblastomas are the most frequently diagnosed form of malignant brain tumors among adults.
Statistically, the survival time of glioblastoma patients amounts on average to 12-14 months after diagnosis, but it can be also considerably higher in individual cases. Final cause of death is due to the space-occupied by the lesion, as well as the tumor-related accumulation of fluid in the brain tissue, which places excessive pressure on vitally important regions of the brain.
The Anni-Hofmann Foundation exclusively supports medical research on glioblastoma. It aims to explore the body’s own ways of defending itself against malignancies and stabilizing healthy cell generation.